Generative AI: It’s only just begun
The use of ChatGPT may be premature to replace anterior segment experts.
The use of ChatGPT may be premature to replace anterior segment experts.
In this episode of CRST: The Podcast, William F. Wiley, MD, joins John F. Doane, MD, FACS, and Michael D. Greenwood, MD, to tackle some of…
The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal injection in 3 cohorts.
The current mission statement of the American Glaucoma Society (AGS) states:
A 37-year-old Black woman presented with bilateral panuveitis and retinal vasculitis. Laboratory workup demonstrated normal angiotensin-converting enzyme and elevated lysozyme. Computed tomography chest scan revealed…
The first International Glaucoma Symposium will be held by Heidelberg Engineering in conjunction with Mainz University on February 1, 2025. Bringin
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
Nominate your candidate for The Ophthalmologist Power List, which celebrates the most inspiring and influential in the eye care industry
ther social determinants of health are associated with undergoing treatment with laser trabeculoplasty (LTP) among individuals with ocular hypertension (OHT) or mild or moderate primary…
Linsitinib is being evaluated in patients with active, moderate to severe thyroid eye disease (TED).
A 13-year-old boy exhibited nystagmus, photoaversion, and blurred vision, with best-corrected visual acuity of 20/100 bilaterally. Born of consanguineous parents, fundus examination revealed sharply defined,…